BioLife Solutions, Inc. (BLFS)

BioLife Solutions Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-62.93	-66.43	-139.81	-8.91	1.82	-1.66
Depreciation & Amortization	11.38	12.7	19.96	14.92	5.81	2.31
Share-Based Compensation	30.49	31.67	25.33	13.96	6.04	3.04
Other Operating Activities	6.8	9.56	86.03	-24.56	-7.02	-2.48
Operating Cash Flow	-14.26	-12.5	-8.49	-4.59	6.65	1.21
Operating Cash Flow Growth	-	-	-	-	447.82%	-48.34%
Capital Expenditures	-7.76	-11.24	-13.92	-14.75	-7.41	-2.33
Acquisitions	0	0	0	1.56	-16.94	-24.69
Change in Investments	22.45	29.07	-44.2	0	0	0
Other Investing Activities	-	-	-	-	-0.36	-
Investing Cash Flow	14.69	17.84	-58.12	-13.19	-24.72	-27.02
Share Issuance / Repurchase	10.63	10.75	0.32	1.42	101.63	1.76
Debt Issued / Paid	-0.5	-0.22	16.46	-3.93	0.98	0
Other Financing Activities	0.07	0.06	-0.47	-0.27	-0.54	-0.16
Financing Cash Flow	10.2	10.59	16.32	-2.78	102.08	1.6
Exchange Rate Effect	0.02	0.04	-0.11	-0.02	0	0
Net Cash Flow	10.63	15.93	-50.29	-20.56	84.01	-24.21
Free Cash Flow	-22.02	-23.74	-22.41	-19.34	-0.77	-1.12
Free Cash Flow Margin	-16.04%	-16.57%	-13.85%	-16.23%	-1.59%	-4.08%
Free Cash Flow Per Share	-0.48	-0.54	-0.53	-0.50	-0.03	-0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).